Background: Immunotherapy is an emerging antitumor therapy that can improve the survival of patients with advanced non-small-cell lung cancer (NSCLC). However. only about 20% of NSCLC patients can benefit from this treatment. At present. https://www.diegojavierfares.com/amazing-find-Dinah-Lace-Front-Synthetic-Wig-by-Bobbi-Boss-limited-save/